Omicron XBB.1.16-Adapted Vaccine for COVID-19: Interim Immunogenicity and Safety Clinical Trial Results

by on 11 de novembre de 2024 with No hi ha comentaris
  • Fernández, M., Narejos, S., Castro, A., Echave-Sustaeta, J., Forner, M., Arana-Arri, E.,…Martínez, S. (2024). Omicron XBB.1.16-Adapted Vaccine for COVID-19: Interim Immunogenicity and Safety Clinical Trial Results. Vaccines, 12, Article 840. https://doi.org/10.3390/vaccines12080840

Deixa un comentari

L'adreça electrònica no es publicarà. Els camps necessaris estan marcats amb *